Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,084 across all filing types
Latest filing 2023-10-05 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of regulatory disclosure regarding significant shareholding and takeover-related activity is classified as a Major Shareholding Notification (MRQ) within the provided schema, as it specifically details the discloser's interests, short positions, and dealings in the target company's securities.
2023-10-05 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Horizon Therapeutics PLC). This is a specific regulatory disclosure form related to major shareholding and takeover activity, which falls under the 'Major Shareholding Notification' category.
2023-10-04 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, for Horizon Therapeutics PLC). This type of regulatory disclosure regarding major shareholding and takeover-related activity is classified as a Major Shareholding Notification (MRQ) within the provided schema.
2023-10-03 English
Form 8.3 - Horizon Therapeutics PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, Horizon Therapeutics PLC). This type of filing is a standard regulatory disclosure regarding major shareholding and derivative positions during an M&A event. Since it does not fit into the specific categories of 'Major Shareholding Notification' (which usually refers to standard TR-1 filings) or 'M&A Activity' (which refers to the company's own announcements), it is best classified as a Regulatory Filing (RNS) as it is a mandatory disclosure submitted to a Regulatory Information Service.
2023-10-02 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997, and the Takeover Rules, 2022. It details the shareholding position and dealings of Citadel Group in Horizon Therapeutics PLC. This type of filing is a standard regulatory requirement for major shareholders or parties involved in a takeover/merger scenario to disclose their interests. Since it specifically relates to significant shareholding notifications and takeover-related disclosures, it falls under the 'Major Shareholding Notification' category.
2023-09-29 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in the context of a takeover offer (in this case, Horizon Therapeutics PLC). This type of regulatory disclosure regarding shareholdings and takeover-related activity is classified as a Major Shareholding Notification (MRQ) within the provided schema, as it details significant ownership levels and changes in interest during a takeover process.
2023-09-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.